Kazia Therapeutics Ltd ADR (ADR)
General ticker "KZIA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $31.9M (TTM average)
Kazia Therapeutics Ltd ADR (ADR) follows the US Stock Market performance with the rate: 39.7%.
Estimated limits based on current volatility of 5.0%: low 7.01$, high 7.75$
Short-term KZIA quotes
Long-term KZIA plot
Financial data
| YTD | 2025-06-30 |
|---|---|
| Operating Revenue | AUD0.04MM |
| Operating Expenses | AUD14.26MM |
| Operating Income | AUD-14.22MM |
| Non-Operating Income | AUD-8.23MM |
| R&D Expense | AUD7.33MM |
| Income(Loss) | AUD-22.45MM |
| Taxes | AUD-1.75MM |
| Net Income(Loss)* | AUD-20.70MM |
| Stockholders Equity | AUD-8.30MM |
| Assets | AUD6.06MM |
| Operating Cash Flow | AUD-13.28MM |
| Financing Cash Flow | AUD15.98MM |
| Earnings Per Share** | AUD-18.90 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.